These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22803179)

  • 1. Immunohistochemical characteristics of desmoid tumors.
    Dubova EA; Sidorenko TV; Shchyogolev AI; Adamyan AA
    Bull Exp Biol Med; 2012 Apr; 152(6):743-7. PubMed ID: 22803179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
    Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
    Huang PW; Tzen CY
    Pathology; 2010 Feb; 42(2):147-50. PubMed ID: 20085516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
    Le Guellec S; Soubeyran I; Rochaix P; Filleron T; Neuville A; Hostein I; Coindre JM
    Mod Pathol; 2012 Dec; 25(12):1551-8. PubMed ID: 22766794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
    Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some desmoid tumors are characterized by trisomy 8.
    Dal Cin P; Sciot R; Aly MS; Delabie J; Stas M; De Wever I; Van Damme B; Van den Berghe H
    Genes Chromosomes Cancer; 1994 Jun; 10(2):131-5. PubMed ID: 7520266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imaging of extraabdominal aggressive fibromatosis].
    Baumgartner K; Bösmüller H; Horger M; Kloth C
    Rofo; 2020 Sep; 192(9):817-820. PubMed ID: 31994152
    [No Abstract]   [Full Text] [Related]  

  • 8. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Intra-abdominal Solid-cystic Desmoid That Emerged after Distal Gastrectomy.
    Takinami M; Matsubayashi H; Ishiwatari H; Uesaka K; Okamura Y; Sasaki K; Ohike N; Hirabayashi K; Ono H
    Intern Med; 2019; 58(24):3525-3529. PubMed ID: 31839672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].
    Kadmon M; Möslein G; Buhr HJ; Herfarth C
    Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
    Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
    Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.
    Hamada S; Futamura N; Ikuta K; Urakawa H; Kozawa E; Ishiguro N; Nishida Y
    PLoS One; 2014; 9(5):e96391. PubMed ID: 24788118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extra-abdominal fibromatosis--extra-abdominal desmoid. Review and personal experiences].
    Piza-Katzer H; Rhomberg M
    Chirurg; 2000 Aug; 71(8):904-11. PubMed ID: 11013809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis.
    Colombo C; Bolshakov S; Hajibashi S; Lopez-Terrada L; Wang WL; Rao P; Benjamin RS; Lazar AJ; Lev D
    Histopathology; 2011 Aug; 59(2):336-40. PubMed ID: 21884214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
    Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
    Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and interphase cytogenetic analysis of desmoid tumours.
    Kouho H; Aoki T; Hisaoka M; Hashimoto H
    Histopathology; 1997 Oct; 31(4):336-41. PubMed ID: 9363449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A to Z of desmoid tumors.
    Shinagare AB; Ramaiya NH; Jagannathan JP; Krajewski KM; Giardino AA; Butrynski JE; Raut CP
    AJR Am J Roentgenol; 2011 Dec; 197(6):W1008-14. PubMed ID: 22109314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggressive muscular-aponeurotic fibromatosis. Its clinical picture and morphological study].
    Popkhristova E; Viiachki I; Cherneva K; Viiachki D
    Khirurgiia (Sofiia); 1993; 46(3):49-51. PubMed ID: 8264194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.
    Colombo C; Belfiore A; Paielli N; De Cecco L; Canevari S; Laurini E; Fermeglia M; Pricl S; Verderio P; Bottelli S; Fiore M; Stacchiotti S; Palassini E; Gronchi A; Pilotti S; Perrone F
    Mol Oncol; 2017 Nov; 11(11):1495-1507. PubMed ID: 28627792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
    Sakai T; Nishida Y; Hamada S; Koike H; Ikuta K; Ota T; Ishiguro N
    Diagn Pathol; 2017 Aug; 12(1):66. PubMed ID: 28851389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.